AI News NQ Analysis

Alleviating premenstrual depression with lactic acid bacteria: Joint patent application filed for the Femtech effects of the KB-1 strain.

NQ Score 50/100

AI Summary (NQ-processed)

Lactic acid bacteria strain KB-1 found to alleviate PMS-related depression; joint patent application filed for new application.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the main outcome of the joint research between LAB Biotech and Cosmo Bio?
A: They confirmed that the KB-1 lactic acid bacteria strain improves PMS symptoms and filed a joint patent application.
Q: Which companies conducted the joint research on the effects of the KB-1 strain?
A: The joint research was conducted by LAB Biotech Co., Ltd. and Cosmo Bio Co., Ltd.
Q: What percentage of Japanese women are reported to experience discomfort before menstruation?
A: It is reported that seventy to eighty percent of Japanese women experience some form of discomfort before menstruation.
Q: What are the known characteristics of the lactic acid bacteria Pediococcus sp. KB-1?
A: It is isolated from white turnips in Hokkaido and possesses immunostimulatory, anti-allergic, and gastric acid-resistant properties.
Q: What percentage of women in their twenties to forties suffer from PMS symptoms severe enough to hinder their daily lives?
A: Approximately five point three percent, or one in twenty women in their twenties to forties, suffer from such severe symptoms.